Cargando…

Proteasomal inhibition sensitizes cervical cancer cells to mitomycin C-induced bystander effect: the role of tumor microenvironment

Inaccessibility of drugs to poorly vascularized strata of tumor is one of the limiting factors in cancer therapy. With the advent of bystander effect (BE), it is possible to perpetuate the cellular damage from drug-exposed cells to the unexposed ones. However, the role of infiltrating tumor-associat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, S V, Ajay, A K, Mohammad, N, Malvi, P, Chaube, B, Meena, A S, Bhat, M K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632313/ https://www.ncbi.nlm.nih.gov/pubmed/26492368 http://dx.doi.org/10.1038/cddis.2015.292

Ejemplares similares

Mitomycin C induces bystander killing in homogeneous and heterogeneous hepatoma cellular models
por: Kumari, Ratna, et al.
Publicado: (2009)

Editorial: Cancer metabolism: molecular insights, metabolic crosstalk in the tumor microenvironment, and implications for therapy
por: Chaube, Balkrishna, et al.
Publicado: (2023)

Targeting metabolic flexibility by simultaneously inhibiting respiratory complex I and lactate generation retards melanoma progression
por: Chaube, Balkrishna, et al.
Publicado: (2015)

AMPK maintains energy homeostasis and survival in cancer cells via regulating p38/PGC-1α-mediated mitochondrial biogenesis
por: Chaube, B, et al.
Publicado: (2015)

The role of the tumor microbe microenvironment in the tumor immune microenvironment: bystander, activator, or inhibitor?
por: Ma, Jiayao, et al.
Publicado: (2021)

Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma
por: Mohammad, Naoshad, et al.
Publicado: (2014)

Intratumoral Platelets: Harmful or Incidental Bystanders of the Tumor Microenvironment?
por: Le Chapelain, Ophélie, et al.
Publicado: (2022)

Strategy to enhance efficacy of doxorubicin in solid tumor cells by methyl-β-cyclodextrin: Involvement of p53 and Fas receptor ligand complex
por: Mohammad, Naoshad, et al.
Publicado: (2015)

RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells
por: Zhang, Zhengkui, et al.
Publicado: (2022)

Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno‐microenvironment in multiple myeloma
por: Barbato, Alessandro, et al.
Publicado: (2023)

Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state
por: Malvi, Parmanand, et al.
Publicado: (2018)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

The effects of three bioreductive drugs (mitomycin C, RSU-1069 and SR4233) on cell lines selected for their sensitivity to mitomycin C or ionising radiation.
por: Keohane, A., et al.
Publicado: (1990)

Brca2 deficiency drives gastrointestinal tumor formation and is selectively inhibited by mitomycin C
por: Chen, Xiaomin, et al.
Publicado: (2020)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Mechanism of differential sensitivity of human bladder cancer cells to mitomycin C and its analogue.
por: Xu, B. H., et al.
Publicado: (1994)

MRC5 and QU-DB bystander cells can produce bystander factors and induce radiation bystander effect
por: Toossi, Mohammad Taghi Bahreyni, et al.
Publicado: (2014)

Aberrant lipid metabolism in cancer cells and tumor microenvironment: the player rather than bystander in cancer progression and metastasis
por: Yu, Xiujing, et al.
Publicado: (2021)

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy
por: Zemek, Rachael M., et al.
Publicado: (2020)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
por: Das, Manisit, et al.
Publicado: (2020)

Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy
por: Dachs, Gabi U., et al.
Publicado: (2009)

Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients
por: Golan, Talia, et al.
Publicado: (2015)

Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade
por: Abril-Rodriguez, Gabriel, et al.
Publicado: (2022)

Bystander
por: Gorky, Maksim, 1868-1936
Publicado: (1930)

Contribution of the Tumor Microenvironment to Metabolic Changes Triggering Resistance of Multiple Myeloma to Proteasome Inhibitors
por: Schwestermann, Jonas, et al.
Publicado: (2022)

Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation
por: Erdmann, Kati, et al.
Publicado: (2017)

Combination chemotherapy in advanced gastrointestinal cancers: ex vivo sensitivity to gemcitabine and mitomycin C
por: Whitehouse, P A, et al.
Publicado: (2003)

Aspirin Delimits Platelet Life Span by Proteasomal Inhibition
por: Nayak, Manasa K., et al.
Publicado: (2014)

AMPK, a key regulator of metabolic/energy homeostasis and mitochondrial biogenesis in cancer cells
por: Chaube, B, et al.
Publicado: (2016)

Human endogenous retroviruses and multiple sclerosis: Innocent bystanders or disease determinants?
por: Antony, Joseph M., et al.
Publicado: (2011)

Human papillomavirus 18 E6 inhibits phosphorylation of p53 expressed in HeLa cells
por: Ajay, Amrendra K, et al.
Publicado: (2012)

Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistance
por: Malvi, Parmanand, et al.
Publicado: (2016)

Upregulation of Protein Synthesis and Proteasome Degradation Confers Sensitivity to Proteasome Inhibitor Bortezomib in Myc-Atypical Teratoid/Rhabdoid Tumors
por: Tran, Huy Minh, et al.
Publicado: (2020)

Consequences of inadvertent intravitreal Mitomycin C injection
por: Mirshahi, Ahmad, et al.
Publicado: (2018)

Bystander CPR
por: Eisenberg, Mickey
Publicado: (1994)

Transconjunctival penetration of mitomycin C
por: Velpandian, T, et al.
Publicado: (2008)

Outcomes of Photorefractive Keratectomy with Intraoperative Mitomycin-C
por: Ghoreishi, Mohammad, et al.
Publicado: (2009)

DNA Adducts of Decarbamoyl Mitomycin C Efficiently Kill Cells without Wild-Type p53 Resulting from Proteasome-Mediated Degradation of Checkpoint Protein 1
por: Boamah, Ernest K., et al.
Publicado: (2010)

Comparing the level of bystander effect in a couple of tumor and normal cell lines
por: Soleymanifard, Shokouhozaman, et al.
Publicado: (2012)

Stressing the Ubiquitin-Proteasome System without 20S Proteolytic Inhibition Selectively Kills Cervical Cancer Cells
por: Anchoori, Ravi K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ieclclf19p381tuhss6t7ic4ud